Circulating adiponectin levels are reduced in obese individuals, and it was proposed to have a crucial role in the pathogenesis of atherosclerosis and cardiovascular diseases associated with obesity and metabolic syndrome. This evidence concerns the gene ADIPOQ and cardiovascular disorder.